Literature DB >> 18370522

Successful use of transdermal fentanyl in patients with cancers of the prostate, ovary and stomach.

K Patterson1, S O'Donoghue.   

Abstract

Entities:  

Year:  1998        PMID： 18370522     DOI： 10.2165/00044011-199816010-00011

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  3 in total

1.  Comparison of the analgesic and intestinal effects of fentanyl and morphine in rats.

Authors:  A A Megens; K Artois; J Vermeire; T Meert; F H Awouters
Journal:  J Pain Symptom Manage       Date:  1998-04       Impact factor: 3.612

2.  Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group.

Authors:  S Ahmedzai; D Brooks
Journal:  J Pain Symptom Manage       Date:  1997-05       Impact factor: 3.612

3.  Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain.

Authors:  Barbara Donner; Michael Zenz; Michael Tryba; Michael Strumpf
Journal:  Pain       Date:  1996-03       Impact factor: 6.961
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.